EC145: a novel targeted agent for adenocarcinoma of the lung

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.5, 2012-05, pp. : 755-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel targeted agents in the treatment of lung cancer

By Saba Nabil Khuri Fadlo

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 6, 2004-06 ,pp. : 609-629

Informa Healthcare

Access to resources Recommend Favorite

Novel targeted agents for the treatment of lung cancer in China

By LiuSi-Yang MokTony WuYi-Long

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 3089-3096

Blackwell Publishing

Access to resources Recommend Favorite

Polymer-Based Novel Lung Targeted Delivery Systems

Current Pharmaceutical Design, Vol. 23, Iss. 3, 2017-02 ,pp. : 373-392

Bentham Science Publishers

Access to resources Recommend Favorite

Medicines access targeted for EC action

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 285, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 530-540

Bentham Science Publishers

Access to resources Recommend Favorite